Showing results (111-120 of 130) with videos related to
Sort By:
Pageof 13
Diabetes, Obesity & Metabolism|September 8, 2025
Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 studyChisom Kanu, Kristina S Boye, Jiat Ling Poon, et al.Advances in Therapy|April 30, 2026
The Value and Impact of Weight Reduction from the Perspective of People in Canada with Type 2 DiabetesMelissa M Ross, Sarah Mulnick, Kristina S Boye, et al.Journal of Medical Economics|February 13, 2024
Health state utilities associated with weight loss: preferences of people with type 2 diabetes and obesity in JapanLouis S Matza, Katie D Stewart, Josefine Redig, et al.Patient Preference and Adherence|November 18, 2020
Patient-Reported Outcomes and Impact of Type 2 Diabetes: A Cross-Sectional Study in the Kingdom of Saudi ArabiaHeather L Gelhorn, Kristina S Boye, Huda Shalhoub, et al.Current Medical Research and Opinion|March 16, 2007
Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomesJoshua A Ray, Kristina S Boye, Nicole Yurgin, et al.Diabetes, Obesity & Metabolism|July 24, 2025
Improvement in body mass index category was associated with improved cardiometabolic measures and patient-reported outcomes in adults with type 2 diabetes treated with tirzepatideRodolfo J Galindo, Clare J Lee, Sheryl Elaine Allen, et al.Journal of Medical Economics|November 4, 2021
Health state utilities associated with weight loss in type 2 diabetes and obesityKristina S Boye, Louis S Matza, Katie D Stewart, et al.Patient Preference and Adherence|June 21, 2018
Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetesLouis S Matza, Kristina S Boye, Jessica B Jordan, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 4, 2020
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported OutcomesKristina S Boye, Hélène Sapin, Luis-Emilio García-Pérez, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 1, 2023
Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial ProgrammeKristina S Boye, Vivian Thuyanh Thieu, Hélène Sapin, et al.Pageof 13